Welcome to Multibagg AI
Log in to access personalized features
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Crestchem Ltd (CRSTCHM) is currently trading at 121.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Crestchem Limited, founded in April 1991, operates in the specialty chemicals sector, focusing on processing, manufacturing, trading, and marketing innovative chemical ingredients. The company focuses on Caprylic/Capric Triglycerides, which are available in both oil and powder form, used across various industrial applications. Crestchem Limited has developed Capric/Caprylic Triglycerides and Lactose Free products, showcasing its innovation in nutritional chemicals through indigenous technology. The firm leverages its strong innovation capabilities to introduce new chemical solutions, enhancing its market position. Despite lacking recent operational data, the emphasis on product development suggests a strategic focus on expanding its specialty chemicals portfolio.
Over the past 52 weeks, Crestchem Ltd has traded between a low of ₹73.01 and a high of ₹230.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Crestchem Ltd has a market capitalization of approximately 38.19. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Crestchem Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 17.20 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 38.19 Cr, Crestchem Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Crestchem Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Crestchem Ltd is 17.20. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Subsidiary formation
Crestchem Limited’s newly incorporated subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED (Crestchem 75% holding), has filed Form INC‑20A and commenced business; it plans a pilot plant and product development in Bangalore with production targeted FY2026‑27/FY2027‑28.
New Subsidiary
Board approved formation of subsidiary OLEO BIOSCIENSES Pvt Ltd (CIN U20110KA2026PTC218609) in Bangalore with initial capital Rs1,000,000; Crestchem subscribed Rs750,000 (75%); project is at pilot/concept stage, rental agreement signed and director authorised to act.
Subsidiary Formation
Board approved formation of OLEO BIOSCIENSES PRIVATE LIMITED (CIN U20110KA2026PTC218609) in Bangalore as Crestchem's subsidiary with initial capital Rs1,000,000; Crestchem subscribed 75% (Rs750,000); pilot project in preliminary stage, no revenue yet.
Subsidiary formation
Board meeting (07-May-2026) to note formation of OLEO BIOSCIENSES Pvt Ltd (Bengaluru) as a Crestchem subsidiary; initial capital Rs1,000,000 with Crestchem subscribing Rs750,000 on 22-Apr-2026; MD authorised; pilot plant conceptual, rental secured, no major capex yet.
Subsidiary formation
Board meeting on 07‑May‑2026 to take note of formation of OLEO BIOSCIENSES PRIVATE LIMITED (Bengaluru) with initial capital Rs.1,000,000; Crestchem subscribed 75% (Rs.750,000); MD authorised; pilot‑plant shed rented; project at conceptual stage.
Bearish
3
Neutral
6
Bullish
5
Bearish
8
Neutral
6
Bullish
32
Bearish
5
Neutral
0
Bullish
27
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
689.95 | 50 Cr | 16.71 | 1.05 | 0.00 | 4.59 | 6.34 | 5.90 | ||
13.92 | 41 Cr | -6.18 | 0.05 | 0.00 | -0.91 | -0.60 | -0.41 | ||
91.50 | 38 Cr | 17.20 | 4.73 | 0.79 | 25.09 | 33.05 | 16.38 | ||
106.60 | 34 Cr | 18.29 | 0.70 | 0.89 | 3.70 | 6.03 | 2.21 | ||
43.49 | 24 Cr | 27.30 | 3.99 | 0.00 | 18.07 | 8.22 | 1.14 | ||
315.00 | 23 Cr | 46.46 | 2.48 | 0.00 | 1.41 | 4.27 | 4.15 | ||
46.00 | 22 Cr | -13.65 | 2.78 | 0.00 | -20.48 | -15.65 | -10.45 | ||
| Median: 7 Co. | — | 91.50 | 34 Cr | 17.20 | 2.48 | 0.00 | 3.70 | 6.03 | 2.21 |
Crestchem Limited, founded in April 1991, operates in the specialty chemicals sector, focusing on processing, manufacturing, trading, and marketing innovative chemical ingredients.
The company focuses on Caprylic/Capric Triglycerides, which are available in both oil and powder form, used across various industrial applications.
Crestchem Limited has developed Capric/Caprylic Triglycerides and Lactose Free products, showcasing its innovation in nutritional chemicals through indigenous technology.
The firm leverages its strong innovation capabilities to introduce new chemical solutions, enhancing its market position.
Despite lacking recent operational data, the emphasis on product development suggests a strategic focus on expanding its specialty chemicals portfolio.
Chemicals & Petrochemicals
Specialty Chemicals
36 Cr
High Risk
16.3
44.3
0.3
4.7
230.00
73.01
Sales CAGR
Profit CAGR
ROE
ROCE
